China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)

Market Cap	20.28B
Revenue (ttm)	11.15B
Net Income (ttm)	1.62B
Shares Out	1.03B
EPS (ttm)	1.58
PE Ratio	12.53
Forward PE	11.50
Dividend	0.47 (2.41%)
Ex-Dividend Date	Nov 8, 2024

Volume	5,714,819
Average Volume	9,003,131
Open	19.73
Previous Close	19.74
Day's Range	19.68 - 19.88
52-Week Range	17.19 - 26.15
Beta	0.09
RSI	65.76
Earnings Date	Aug 22, 2025

About SHA:600062

China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People’s Republic of China. The company offers pharmaceutical products for blood pressure, blood sugar, injection, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, and other. The company was founded in 1939 and is headquartered in Beijing, the People’s Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a subsidiary of Beijing Pharmaceutical Group Co., Ltd.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1939
• Employees: 13,414
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600062

Financial Performance

In 2024, SHA:600062's revenue was 11.21 billion, a decrease of -0.87% compared to the previous year's 11.31 billion. Earnings were 1.63 billion, a decrease of -2.55%.